Abstract
Introduction
Neuropathy is one of the most common complications of diabetes, which causes many problems for diabetic patients. Thus, the aim of the present study was to investigate the prevalence of neuropathy among type 1 diabetic adolescents by systematic review and meta-analysis.
Materials and methods
This study is a systematic review and meta-analysis, which reviewed articles published from 2001 to September 1, 2018. The search process was carried out in the Google Scholar search engine and domestic and international databases such as Magiran, SID, Iranmedex, IranDoc, Medlib, PubMed, Scopus, Science Direct, Springer, Wiley Online Library, Web of Science, Ebsco and Cochrane using Persian and English keywords based on MESH conformity. All the research steps were carried out by two members of the research team who were familiar with systematic reviews and meta-analysis data, using the software CMA. Analysis of meta-regression and the use of a random effects model were introduced and analyzed.
Findings
When a systematic search was carried out on the reviewed articles, five of them were included in the meta-analysis phase. The sample size was 484, and the prevalence of diabetic peripheral neuropathy (DPN) in type 1 diabetic patients was 28.2% [confidence interval (CI) = 19.5–39.1]. The findings of the meta-regression analysis showed that the DPN prevalence rate decreased with increasing age (Q = 5.77 p = 0.016), and the results of more recent studies showed an increase in the DPN incidence rate (Q = 20.62, p < 0.001).
Conclusion
The findings of the present study revealed that although the prevalence of neuropathy in diabetic adolescents was not high, the prevalence was significant. Considering the increasing prevalence of diabetes and its impact on the health status of patients, appropriate interventions should be conducted to prevent diabetes and subsequent diabetic neuropathy.
Funding source: Kermanshah University of Medical Sciences
Award Identifier / Grant number: 3006963
Funding statement: This article was approved by the Student research committee of Kermanshah University of Medical Sciences with the Project Code 3006963, Funder Id: 10.13039/501100005317. Therefore, the researchers are grateful to the center.
References
[1] Mohammadi M, Raiegan V, Akbar A, Mirzaei M, Zahednezhad H, Jalali R, et al. Prevalence of underweight in Iranian children: a systematic review and meta-analysis. Tehran Univ Med J. 2018;76(4):241–9.Search in Google Scholar
[2] Moţăţăianu A, Maier S, Bajko Z, Voidazan S, Bălaşa R, Stoian A. Cardiac autonomic neuropathy in type 1 and type 2 diabetes patients. BMC Neurol. 2018;18(1):126.10.1186/s12883-018-1125-1Search in Google Scholar PubMed PubMed Central
[3] Shohani M, Tavan H. Arbitrary use of insulin and its consequence. Iran J Public Health. 2018;47(8):1226–7.Search in Google Scholar
[4] Cheraghi F, Mortazavi S, Shamsaei F, Moghimbeigi A. Effect of education on management of blood glucose in children with diabetes. J Nurs Educ. 2014;3(1):1–11.Search in Google Scholar
[5] Esteghamati A, Larijani B, Aghajani MH, Ghaemi F, Kermanchi J, Shahrami A, et al. Diabetes in Iran: prospective analysis from first nationwide diabetes report of National Program for Prevention and Control of Diabetes (NPPCD-2016). Sci Rep. 2017;7(1):13461.10.1038/s41598-017-13379-zSearch in Google Scholar PubMed PubMed Central
[6] Papatheodorou K, Banach M, Edmonds M, Papanas N, Papazoglou D. Complications of diabetes. J Diabetes Res. 2015;2015. DOI: 10.1155/2015/189525.Search in Google Scholar PubMed PubMed Central
[7] De Groot M, Anderson R, Freedland KE, Clouse RE, Lustman PJ. Association of depression and diabetes complications: a meta-analysis. Psychosom Med. 2001;63(4):619–30.10.1097/00006842-200107000-00015Search in Google Scholar PubMed
[8] Robinson MÈ, Altenor K, Carpenter C, Bonnell R, Jean‐Baptiste E, von Oettingen J. High rates of ocular complications in a cohort of Haitian children and adolescents with diabetes. Pediatr Diabetes. 2018;19(6):1124–1130. DOI: 10.1111/pedi.12688.Search in Google Scholar PubMed
[9] Feldman MA, Anderson LM, Shapiro JB, Jedraszko AM, Evans M, Weil LE, et al. Family-based interventions targeting improvements in health and family outcomes of children and adolescents with type 1 diabetes: a systematic review. Curr Diab Rep. 2018;18(3):15.10.1007/s11892-018-0981-9Search in Google Scholar PubMed
[10] Moayeri A, Mohamadpour M, Mousavi SF, Shirzadpour E, Mohamadpour S, Amraei M. Fracture risk in patients with type 2 diabetes mellitus and possible risk factors: a systematic review and meta-analysis. Ther Clin Risk Manag. 2017;13:455–68.10.2147/TCRM.S131945Search in Google Scholar PubMed PubMed Central
[11] Amraei M, Mohamadpour S, Sayehmiri K, Mousavi SF, Shirzadpour E, Moayeri A. Effects of vitamin D deficiency on incidence risk of gestational diabetes mellitus: a systematic review and meta-analysis. Front Endocrinol (Lausanne). 2018;9:7.10.3389/fendo.2018.00007Search in Google Scholar PubMed PubMed Central
[12] Mutlu EK, Unver B, Taskiran H, Ozgen IT. An investigation of the foot ankle joint mobility, muscle strength, and foot structure in adolescent with type 1 diabetes. Int J Diabetes Dev Ctries. 2018;38(1):108–14.10.1007/s13410-017-0556-3Search in Google Scholar
[13] Elbarbary NS, Ismail EAR, El‐Naggar AR, Hamouda MH, El‐Hamamsy M. The effect of 12 weeks carnosine supplementation on renal functional integrity and oxidative stress in pediatric patients with diabetic nephropathy: a randomized placebo‐controlled trial. Pediatr Diabetes. 2018;19(3):470–7.10.1111/pedi.12564Search in Google Scholar PubMed
[14] Peng S, Li C, Sun X. Complications of diabetes diagnosed in children and adolescents. J Am Med Assoc. 2017;317(24):2552–3.10.1001/jama.2017.6223Search in Google Scholar PubMed
[15] Olfatifar M, Karami M, Shokri P, Hosseini SM. Prevalence of chronic complications and related risk factors of diabetes in patients referred to the diabetes center of Hamedan Province. Sci J Hamadan Nurs Midwifery Fac. 2017;25(2):69–74.10.21859/nmj-25029Search in Google Scholar
[16] Alvarado-Martel D, Velasco R, Sánchez-Hernández RM, Carrillo A, Nóvoa FJ, Wägner AM. Quality of life and type 1 diabetes: a study assessing patients’ perceptions and self-management needs. Patient Prefer Adherence. 2015;9:1315–23.10.2147/PPA.S87310Search in Google Scholar PubMed PubMed Central
[17] Stahl-Pehe A, Lange K, Bächle C, Castillo K, Holl RW, Rosenbauer J. Mental health problems among adolescents with early-onset and long-duration type 1 diabetes and their association with quality of life: a population-based survey. PLoS One. 2014;9(3):e92473.10.1371/journal.pone.0092473Search in Google Scholar PubMed PubMed Central
[18] Castellano-Guerrero A, Guerrero R, Relimpio F, Losada F, Mangas M, Pumar A, et al. Prevalence and predictors of depression and anxiety in adult patients with type 1 diabetes in tertiary care setting. Acta Diabetol. 2018;55:943–53.10.1007/s00592-018-1172-5Search in Google Scholar PubMed
[19] Schram MT, Baan CA, Pouwer F. Depression and quality of life in patients with diabetes: a systematic review from the European Depression in Diabetes (EDID) research consortium. Curr Diabetes Rev. 2009;5(2):112–9.10.2174/157339909788166828Search in Google Scholar PubMed PubMed Central
[20] Trotta D, Verrotti A, Salladini C, Chiarelli F. Diabetic neuropathy in children and adolescents. Pediatr Diabetes. 2004;5(1):44–57.10.1111/j.1399-543X.2004.00041.xSearch in Google Scholar PubMed
[21] Salvotelli L, Stoico V, Perrone F, Cacciatori V, Negri C, Brangani C, et al. Prevalence of neuropathy in type 2 diabetic patients and its association with other diabetes complications: the Verona Diabetic Foot Screening Program. J Diabetes Complications. 2015;29(8):1066–70.10.1016/j.jdiacomp.2015.06.014Search in Google Scholar PubMed
[22] Kim SS, Won JC, Kwon HS, Kim CH, Lee JH, Park TS, et al. Prevalence and clinical implications of painful diabetic peripheral neuropathy in type 2 diabetes: results from a nationwide hospital-based study of diabetic neuropathy in Korea. Diabetes Res Clin Pract. 2014;103(3):522–9.10.1016/j.diabres.2013.12.003Search in Google Scholar PubMed
[23] Louraki M, Katsalouli M, Kanaka-Gantenbein C, Kafassi N, Critselis E, Kallinikou D, et al. The prevalence of early subclinical somatic neuropathy in children and adolescents with Type 1 diabetes mellitus and its association with the persistence of autoantibodies to glutamic acid decarboxylase (GAD) and islet antigen-2 (IA-2). Diabetes Res Clin Pract. 2016;117:82–90.10.1016/j.diabres.2016.04.044Search in Google Scholar PubMed
[24] Abbott CA, Malik RA, Ernest R, Kulkarni J, Boulton AJ. Prevalence and characteristics of painful diabetic neuropathy in a large community-based diabetes population in the UK. Diabetes Care. 2011:34:2220–4.10.2337/dc11-1108Search in Google Scholar PubMed PubMed Central
[25] Hasani N, Khosrawi S, Hashemipour M, Haghighatiyan M, Javdan Z, Taheri MH, et al. Prevalence and related risk-factors of peripheral neuropathy in children with insulin-dependent diabetes mellitus. J Res Med Sci. 2013;18(2):132–6.Search in Google Scholar
[26] Ghaemi N, Hasanabadi H, Ashrafzadeh F, Sarvari S, Rahimi H, Hashemian S. Peripheral neuropathy in children and adolescents with insulin-dependent diabetes mellitus. Iran J Child Neurol. 2018;12(2):83–90.Search in Google Scholar
[27] Sobhani S, Asayesh H, Sharifi F, Djalalinia S, Baradaran HR, Arzaghi SM, et al. Prevalence of diabetic peripheral neuropathy in Iran: a systematic review and meta-analysis. J Diabetes Metab Disord. 2014;13(1):97.10.1186/s40200-014-0097-ySearch in Google Scholar PubMed PubMed Central
[28] Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151(4):264–9.10.7326/0003-4819-151-4-200908180-00135Search in Google Scholar PubMed
[29] Von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. PLoS Med. 2007;4(10):e296.10.1097/EDE.0b013e3181577654Search in Google Scholar PubMed
[30] Karamifar H, Mooadab M, Karamizadeh Z, Amirhakimi G. Evaluation of peripheral neuropathy in patients with type 1 diabetes mellitus by bedside scoring procedure. Iran J Pediatr. 2007;17(Suppl 1):54–60.Search in Google Scholar
[31] Khorasani E. Prevalence of peripheral neuropathy and its related factors in diabetic children, Neishabour city, Iran. Int J Pediatr. 2018;6(12):8707–14.Search in Google Scholar
[32] Olfatifar M, Karami M, Hosseini SM, shokri P. Prevalence of chronic complications and related risk factors of diabetes in patients referred to the diabetes center of Hamedan Province. Sci J Hamadan Nurs Midwifery Fac. 2017;25(2):69–74.10.21859/nmj-25029Search in Google Scholar
[33] Kiani J, Moghimbeigi A, Azizkhani H, Kosarifard S. The prevalence and associated risk factors of peripheral diabetic neuropathy in Hamedan, Iran. Arch Iran Med. 2013;16(1):17–9.Search in Google Scholar
[34] Khawaja N, Abu-Shennar J, Saleh M, Dahbour SS, Khader YS, Ajlouni KM. The prevalence and risk factors of peripheral neuropathy among patients with type 2 diabetes mellitus; the case of Jordan. Diabetol Metab Syndr. 2018;10(1):8.10.1186/s13098-018-0309-6Search in Google Scholar PubMed PubMed Central
[35] Pop‐Busui R, Lu J, Lopes N, Jones TL. Prevalence of diabetic peripheral neuropathy and relation to glycemic control therapies at baseline in the BARI 2D cohort. J Peripher Nerv Syst. 2009;14(1):1–13.10.1111/j.1529-8027.2009.00200.xSearch in Google Scholar PubMed PubMed Central
[36] Bai J-W, Lovblom LE, Cardinez M, Weisman A, Farooqi MA, Halpern EM, et al. Neuropathy and presence of emotional distress and depression in longstanding diabetes: results from the Canadian study of longevity in type 1 diabetes. J Diabetes Complications. 2017;31(8):1318–24.10.1016/j.jdiacomp.2017.05.002Search in Google Scholar PubMed
©2019 Walter de Gruyter GmbH, Berlin/Boston
